Pfizer-BioNTech asks FDA to authorize new omicron-targeting COVID booster for children 5 to 11
Pfizer-BioNTech submitted an application for the FDA to authorize its BA.4/BA.5 bivalent COVID-19 vaccine for kids 5 to 11 at a 10-microgram dose.
Pfizer-BioNTech asks FDA to authorize new omicron-targeting COVID booster for children 5 to 11
USATODAY.com
0 shares
1 views
You might like
Related news coverage
Pfizer Seeks To Expand Omicron Booster To 5- To 11-year-olds
Newsy
Watch VideoPfizer asked U.S. regulators Monday to expand use of its updated COVID-19 booster shot to children ages 5 to..
-
Pfizer seeks to expand omicron booster to 5- to 11-year-olds
SeattlePI.com
-
Pfizer seeks to expand omicron booster to 5- to 11-year-olds
SeattlePI.com
-
Pfizer, BioNTech seek FDA nod for Omicron booster targeting children
SeekingAlpha
-
Israel rolls out new omicron-tailored COVID-19 vaccines
SeattlePI.com
Advertisement
More coverage
CDC survey finds that more than half of all babies, toddlers suffer a "systemic reaction" following covid injection
NaturalNews.com
(Natural News) New data from the U.S. Centers for Disease Control and Prevention (CDC) suggests that 55 percent of children between..
-
Updated Omicron Booster Shots Are Now Available For Americans
Newsy
-
Health Officials Are Recommending Americans Get Omicron Booster Shots
Newsy
-
EXPLAINER: Should you get a new COVID booster? If so, when?
SeattlePI.com
-
There's no bad time to get a new COVID booster if you're eligible, CDC director says
NPR